Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in i (Q44413703)
Jump to navigation
Jump to search
scientific article published on January 1, 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in i |
scientific article published on January 1, 2002 |
Statements
1 reference
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in i (English)
1 reference
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the Prospective Evaluation of Dalteparin efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study) (English)
1 reference
PREVENT Investigator Group
1 reference
Paul T. Vaitkus
A. Leizorovicz
1 January 2002
1 reference
1 reference
7
1 reference
4
1 reference
269-273
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference